A citation-based method for searching scientific literature

Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
Times Cited: 100



Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
Times Cited: 106




List of shared articles



Times cited

Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.
Valentina Gallo, Carol Brayne, Lars Forsgren, Roger A Barker, Jesper Petersson, Oskar Hansson, Daniel Lindqvist, Claudio Ruffmann, Lianna Ishihara, Robert Luben,[...]. Neurodegener Dis 2015
8

Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies.
Yun-Liang Wang, Yu-Tong Wang, Jin-Feng Li, Yu-Zheng Zhang, Hong-Lei Yin, Bing Han. PLoS One 2015
34

Reply to: Diabetes and risk of Parkinson's disease.
Natalia Palacios, Alberto Ascherio. Mov Disord 2013
2

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
80



Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
Fares Bassil, Pierre-Olivier Fernagut, Erwan Bezard, Wassilios G Meissner. Prog Neurobiol 2014
142

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
1

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
23

The best medicine? The influence of physical activity and inactivity on Parkinson's disease.
Sara C LaHue, Cynthia L Comella, Caroline M Tanner. Mov Disord 2016
62

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
124

Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.
Samantha Molsberry, Kjetil Bjornevik, Katherine C Hughes, Zhongli Joel Zhang, Sarah Jeanfavre, Clary Clish, Brian Healy, Michael Schwarzschild, Alberto Ascherio. J Parkinsons Dis 2020
3

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.
Iara Pérez-Taboada, Samuel Alberquilla, Eduardo D Martín, Rishi Anand, Stefania Vietti-Michelina, Nchimunya N Tebeka, James Cantley, Stephanie J Cragg, Rosario Moratalla, Mario Vallejo. Mov Disord 2020
17


Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies?
Guadalupe Vidal-Martinez, Barbara Yang, Javier Vargas-Medrano, Ruth G Perez. Front Mol Neurosci 2018
8


Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adults.
Jennifer Kizza, Sarah Lewington, Benjamin Mappin-Kasirer, Iain Turnbull, Yu Guo, Zheng Bian, Yiping Chen, Ling Yang, Zhengming Chen, Robert Clarke. Ann Clin Transl Neurol 2019
11

Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
Daniele Belvisi, Roberta Pellicciari, Giovanni Fabbrini, Michele Tinazzi, Alfredo Berardelli, Giovanni Defazio. Neurobiol Dis 2020
24

Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.
Cynthia Alexandra Martin-Jiménez, Diana Milena Gaitán-Vaca, Valentina Echeverria, Janneth González, George E Barreto. Mol Neurobiol 2017
33

Association Between Diabetic Retinopathy and Parkinson Disease: The Korean National Health Insurance Service Database.
Seung Eun Lee, Kyungdo Han, Ji Yeon Baek, Kyung Soo Ko, Ki-Up Lee, Eun Hee Koh. J Clin Endocrinol Metab 2018
12

Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.
Jesús de Pedro-Cuesta, Pablo Martínez-Martín, Alberto Rábano, Enrique Alcalde-Cabero, Fernando José García López, Javier Almazán-Isla, María Ruiz-Tovar, Maria-José Medrano, Fuencisla Avellanal, Olga Calero,[...]. J Alzheimers Dis 2016
8

Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
Nasimudeen R Jabir, Chelapram K Firoz, Saleh S Baeesa, Ghulam Md Ashraf, Suhail Akhtar, Warda Kamal, Mohammad A Kamal, Shams Tabrez. CNS Neurosci Ther 2015
29


Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
23

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
Annekatrin König, Hugo Vicente Miranda, Tiago Fleming Outeiro. J Parkinsons Dis 2018
20

Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
1

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
37

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
714

Meta-analysis: overweight, obesity, and Parkinson's disease.
Jinhu Chen, Zhenlong Guan, Liqin Wang, Guangyao Song, Boqing Ma, Yanqin Wang. Int J Endocrinol 2014
29

Understanding the links between cardiovascular disease and Parkinson's disease.
Judy Potashkin, Xuemei Huang, Claudia Becker, Honglei Chen, Thomas Foltynie, Connie Marras. Mov Disord 2020
36